AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Kaufmann, M von Minckwitz, G
Citation: M. Kaufmann et G. Von Minckwitz, The emerging role of hormonal ablation as adjuvant therapy in node+ and node- pre-/perimenopausal patients, BREAST, 10, 2001, pp. 123-129

Authors: von Minckwitz, G Costa, SD Raab, G Blohmer, JU Eidtmann, H Hilfrich, J Merkle, E Jackisch, C Gademann, G Tulusan, AH Eiermann, W Graf, E Kaufmann, M
Citation: G. Von Minckwitz et al., Dose-dense doxorubicin, docetaxel, and granulocyte colony-stimulating factor support with or without tamoxifen as preoperative therapy in patients with operable carcinoma of the breast: A randomized, controlled, open phase IIb study, J CL ONCOL, 19(15), 2001, pp. 3506-3515

Authors: Oberhoff, C Kieback, DG Wurstlein, R Deertz, H Sehouli, J van Soest, C Hilfrich, J Mesrogli, M von Minckwitz, G Staab, HJ Schindler, AE
Citation: C. Oberhoff et al., Topotecan chemotherapy in patients with breast cancer and brain metastases: Results of a pilot study, ONKOLOGIE, 24(3), 2001, pp. 256-260

Authors: Kaufmann, M von Minckwitz, G
Citation: M. Kaufmann et G. Von Minckwitz, Report on the NIH consensus development conference on adjuvant therapy of breast carcinoma, ONKOLOGIE, 24(2), 2001, pp. 190-192

Authors: Loibl, S von Minckwitz, G Costa, S Kaufmann, M
Citation: S. Loibl et al., Combination therapy with Docetaxel and mitoxantron for metastatic breast cancer, ONKOLOGIE, 23(3), 2000, pp. 5-6

Authors: von Minckwitz, G Grischke, EM Schwab, S Hettinger, S Loibl, S Aulmann, M Kaufmann, M
Citation: G. Von Minckwitz et al., Predictive value of serum interleukin-6 and-8 levels in preterm labor or rupture of the membranes, ACT OBST SC, 79(8), 2000, pp. 667-672

Authors: Kusterer, K Ludwig, R Hochschulz, P Stegmuller, M Bojunga, J von Minckwitz, G
Citation: K. Kusterer et al., Macrophage and lymphocyte homing in experimental diabetes, EXP CL E D, 107, 1999, pp. S102-S107

Authors: von Minckwitz, G Bauknecht, T Visseren-Grul, CM Neijt, JP
Citation: G. Von Minckwitz et al., Phase II study of gemcitabine in ovarian cancer, ANN ONCOL, 10(7), 1999, pp. 853-855

Authors: Chan, S Friedrichs, K Noel, D Pinter, T Van Belle, S Vorobiof, D Duarte, R Gil, MG Bodrogi, I Murray, E Yelle, L von Minckwitz, G Korec, S Simmonds, P Buzzi, F Mancha, RG Richardson, G Walpole, E Ronzoni, M Murawsky, M Alakl, M Riva, A Crown, J
Citation: S. Chan et al., Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer, J CL ONCOL, 17(8), 1999, pp. 2341-2354

Authors: von Minckwitz, G Costa, SD Eiermonn, W Blohmer, JU Tuluson, AH Jackisch, C Kaufmann, M
Citation: G. Von Minckwitz et al., Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxel, J CL ONCOL, 17(7), 1999, pp. 1999-2005

Authors: Loibl, S von Minckwitz, G Kaufmann, M
Citation: S. Loibl et al., Term pregnancy after adjuvant therapy with GnRH-agonist for breast cancer., TUMORDIAGN, 20(3), 1999, pp. 90-93

Authors: Costa, SD von Minckwitz, G Raab, G Blohmer, JU Dresel, V Eidtmann, H Hilfrich, J Jackisch, C Merkle, E Gademann, G Kaufmann, M
Citation: Sd. Costa et al., The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer, SEMIN ONCOL, 26(3), 1999, pp. 24-31

Authors: Ahr, A Scharl, A Muller, M von Minckwitz, G Gatje, R Pantel, K Kaufmann, M
Citation: A. Ahr et al., Cross-reactive staining of normal bone-marrow cells by monoclonal antibody2E11, INT J CANC, 84(5), 1999, pp. 502-505

Authors: von Minckwitz, G Costa, SD Loibl, S Caminada, MC Kaufmann, M
Citation: G. Von Minckwitz et al., Combination of docetaxel and mitoxantrone for the therapy of metastatic breast cancer - a phase I-II study, TUMORDIAGN, 19(5), 1998, pp. 149-154

Authors: von Minckwitz, G Costa, SD Blohmer, J Eiermann, W Jakisch, C Tulusan, AH Kaufmann, M
Citation: G. Von Minckwitz et al., Preoperative chemotherapy in breast cancer, ZBL CHIR, 123, 1998, pp. 138-141
Risultati: 1-15 |